Rayleigh Optoelectronics
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Rayleigh Optoelectronics - overview
Established
2023
Location
Zhuhai, Guangdong, China
Primary Industry
Medical Devices & Equipment
About
Based in Zhuhai, China and founded in 2023, SCNU Rayleigh Optoelectronics Technology (Zhuhai) Co. , Ltd. , trading as Rayleigh Optoelectronics, is a high-tech enterprise engaged in the research, development, production, and sales of high-end FRET (Fluorescence Resonance Energy Transfer) microscopy imaging systems and the provision of scientific research and testing services. The company was founded by Zhengfei Zhuang and Tongsheng Chen, two professors at South China Normal University (SCNU).
The company has obtained more than 30 independent intellectual property rights and has established partnerships with Tsinghua University, Shanghai Jiao Tong University and Sun Yat-sen University Cancer Hospital. In January 2024, Rayleigh Optoelectronics closed angel funding led by returning investor Zhuhai Zhengling Capital, with participation from new investor Leadway Capital. Rayleigh Optoelectronics' main offerings include living cell microscopy imaging analyzers such as living cell intelligent quantitative FRET microscopy analyzer, fast dual-channel FRET fully automatic imaging analyzer, multimodal FRET fully automatic imaging analyzer, and related supporting LED light sources. The company also develops low-through airtightness testing equipment and offers services such as FRET testing services and fluorescence microscope upgrade and modification (by adding FRET detection and analysis module).
The company generates revenue by providing the optical instrument manufacturing and sales, cell technology R&D and application, and intelligent instrumentation manufacturing. The company will use the angel funding for team building, product iteration, and business development, driving the transformation, industrialization, and commercialization of technological achievements.
Current Investors
Zhuhai Zhengling Venture Capital, Leadway Capital, Zhuhai Zhengling Capital
Primary Industry
Medical Devices & Equipment
Sub Industries
Optometrists & Opticians Products and Services, Diagnostic Equipment
Website
www.rayleigh.com.cn
Verticals
HealthTech, Manufacturing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.